Cargando…
High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal
SETTING: Nine drug-resistant TB centres, some of them supported by Damien Foundation in Nepal where >80% of multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) patients are treated. OBJECTIVE: To assess the uptake, effectiveness and safety of the 9–12-month shorter treatment regimen (STR) in...
Autores principales: | Koirala, S., Shah, N. P., Pyakurel, P., Khanal, M., Rajbhandari, S. K., Pun, T., Shrestha, B., Maharjan, B., Karki, S., Tamang, K. B., Roggi, A., Kumar, A. M. V., Ortuño-Gutiérrez, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575385/ https://www.ncbi.nlm.nih.gov/pubmed/34778014 http://dx.doi.org/10.5588/pha.21.0041 |
Ejemplares similares
-
Annual consumption of parenteral antibiotics in a tertiary hospital of Nepal, 2017–2019: a cross-sectional study
por: Baral, P., et al.
Publicado: (2021) -
High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal
por: Shakya, S., et al.
Publicado: (2021) -
Prevalence of methicillin-resistant Staphylococcus aureus in a tertiary hospital in Nepal
por: Pradhan, P., et al.
Publicado: (2021) -
Incidence of healthcare-associated infections with invasive devices and surgical procedures in Nepal
por: Koju, P., et al.
Publicado: (2021) -
High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal
por: Ghimire, R., et al.
Publicado: (2021)